Your browser doesn't support javascript.
loading
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair.
Dreyfus, Julien; Taramasso, Maurizio; Kresoja, Karl-Patrik; Omran, Hazem; Iliadis, Christos; Russo, Giulio; Weber, Marcel; Nombela-Franco, Luis; Estevez Loureiro, Rodrigo; Hausleiter, Jörg; Latib, Azeem; Stolz, Lukas; Praz, Fabien; Windecker, Stephan; Zamorano, Jose Luis; von Bardeleben, Ralph Stephan; Tang, Gilbert H L; Hahn, Rebecca; Lubos, Edith; Webb, John; Schofer, Joachim; Fam, Neil; Lauten, Alexander; Pedrazzini, Giovanni; Rodés-Cabau, Josep; Nejjari, Mohammed; Badano, Luigi; Alessandrini, Hannes; Himbert, Dominique; Sievert, Horst; Piayda, Kerstin; Donal, Erwan; Modine, Thomas; Nickenig, Georg; Pfister, Roman; Rudolph, Volker; Bernick, Jordan; Wells, George A; Bax, Jeroen; Lurz, Philipp; Enriquez-Sarano, Maurice; Maisano, Francesco; Messika-Zeitoun, David.
Afiliação
  • Dreyfus J; Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France. Electronic address: dreyfusjulien@yahoo.fr.
  • Taramasso M; HerzZentrum Hirslanden Zürich, Zürich, Switzerland.
  • Kresoja KP; Division of Cardiology, University Medical Center, Mainz, Germany.
  • Omran H; General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.
  • Iliadis C; Department for Internal Medicine III, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Russo G; Policlinico Tor Vergata, University of Rome, Rome, Italy.
  • Weber M; Heart Center University Hospital, Bonn, Germany.
  • Nombela-Franco L; Interventional Cardiology, Hospital Clínico San Carlos, Madrid, Spain.
  • Estevez Loureiro R; Interventional Cardiology Clinic, University Hospital Alvaro Cunqueiro, Vigo, Spain.
  • Hausleiter J; Medical Clinic and Polyclinic I, University Hospital of Munich, Munich, Germany.
  • Latib A; Division of Cardiology, Montefiore Medical Center, New York, New York, USA.
  • Stolz L; Medical Clinic and Polyclinic I, University Hospital of Munich, Munich, Germany.
  • Praz F; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
  • Windecker S; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
  • Zamorano JL; Department of Cardiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • von Bardeleben RS; Division of Cardiology, University Medical Center, Mainz, Germany.
  • Tang GHL; Department of Cardiovascular Surgery, Mount Sinai Health System, New York, New York, USA.
  • Hahn R; Cardiology Department, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, USA.
  • Lubos E; Department of Cardiology, University Heart and Vascular Center, Hamburg, Germany.
  • Webb J; St. Paul Hospital, Vancouver, British Columbia, Canada.
  • Schofer J; MVZ-Department for Structural Heart Disease, Asklepios Clinic St. Georg, Hamburg, Germany.
  • Fam N; Division of Cardiology, Toronto Heart Center, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Lauten A; Department of General and Interventional Cardiology and Rhythmology, Helios Klinikum Erfurt, Erfurt, Germany.
  • Pedrazzini G; Division of Cardiology, Cardiocentro Ticino Institute, EOC, Lugano, Switzerland.
  • Rodés-Cabau J; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Nejjari M; Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.
  • Badano L; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Alessandrini H; Department of Cardiology, Asklepios Clinic Sankt Georg, Hamburg, Germany.
  • Himbert D; Division of Cardiology, Bichat Hospital, Paris, France.
  • Sievert H; CardioVascular Center Frankfurt, Frankfurt am Main, Germany.
  • Piayda K; CardioVascular Center Frankfurt, Frankfurt, Germany; Department of Cardiology and Angiology, Universitätsklinikum Gießen und Marburg, Gießen, Germany.
  • Donal E; Cardiology Department, Signal and Image Processing Laboratory UMR1099, French National Institute of Health and Medical Research, University Hospital Center of Rennes, Rennes, France.
  • Modine T; Department of Cardiology and Cardio-Vascular Surgery, Hôpital Cardiologique de Haut-Leveque, Bordeaux University Hospital, Bordeaux, France.
  • Nickenig G; Heart Center University Hospital, Bonn, Germany.
  • Pfister R; Department for Internal Medicine III, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Rudolph V; General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.
  • Bernick J; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada.
  • Wells GA; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Bax J; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Lurz P; Division of Cardiology, University Medical Center, Mainz, Germany.
  • Enriquez-Sarano M; Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
  • Maisano F; Cardiac Surgery and Heart Valve Center, Ospedale San Raffaele, University Vita Salute, Milano, Italy.
  • Messika-Zeitoun D; Department of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada. Electronic address: DMessika-zeitoun@ottawaheart.ca.
JACC Cardiovasc Interv ; 17(12): 1485-1495, 2024 Jun 24.
Article em En | MEDLINE | ID: mdl-38752971
ABSTRACT

BACKGROUND:

The safety profile of transcatheter tricuspid valve (TTV) repair techniques is well established, but residual tricuspid regurgitation (TR) remains a concern.

OBJECTIVES:

The authors sought to assess the impact of residual TR severity post-TTV repair on survival.

METHODS:

We evaluated the survival rate at 2 years of 613 patients with severe isolated functional TR who underwent TTV repair in TRIGISTRY according to the severity of residual TR at discharge using a 3-grade (mild, moderate, and severe) or 4-grade scheme (mild, mild to moderate, moderate to severe, and severe).

RESULTS:

Residual TR was none/mild in 33%, moderate in 52%, and severe in 15%. The 2-year adjusted survival rates significantly differed between the 3 groups (85%, 70%, and 44%, respectively; restricted mean survival time [RMST] P = 0.0001). When the 319 patients with moderate residual TR were subdivided into mild to moderate (n = 201, 33%) and moderate to severe (n = 118, 19%), the adjusted survival rate was also significantly different between groups (85%, 80%, 55%, and 44%, respectively; RMST P = 0.001). Survival was significantly lower in patients with moderate to severe residual TR compared to patients with mild to moderate residual TR (P = 0.006). No difference in survival rates was observed between patients with no/mild and mild to moderate residual TR (P = 0.67) or between patients with moderate to severe and severe residual TR (P = 0.96).

CONCLUSIONS:

The moderate residual TR group was heterogeneous and encompassed patients with markedly different clinical outcomes. Refining TR grade classification with a more granular 4-grade scheme improved outcome prediction. Our results highlight the importance of achieving a mild to moderate or lower residual TR grade during TTV repair, which could define a successful intervention.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Tricúspide / Insuficiência da Valva Tricúspide / Índice de Gravidade de Doença / Cateterismo Cardíaco / Implante de Prótese de Valva Cardíaca Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Tricúspide / Insuficiência da Valva Tricúspide / Índice de Gravidade de Doença / Cateterismo Cardíaco / Implante de Prótese de Valva Cardíaca Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article